Base bibliographique

Sommaire :

Chirurgie des métastases thoraciques des cancers urologiques
2008
- Réf : Prog Urol, 2008, 12, 18, S250, suppl. S7

Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser

  Références

 

Surgery of thoracic metastases from urological malignancies essentially concerns renal carcinoma and non seminomatous testicular germ cell tumors (NSGCT). Complete resection of renal cell cancer lung metastases can be done with low mortality and an appreciable long survival rate, especially for single lesion with a long free interval. For NSGCT, resection of all pulmonary lesions and mediastinal residual masses after chemotherapy affords a very high long term survival rate. In the case of multiple lesions, surgical approaches must be carefully chosen.

Mots clés:
Métastases pulmonaires / Masses médiastinales résiduelles / Exérèse complète / Voies d’abord cancers urologiques
Mots-clés:
Lung metastases / Mediastinal masses / Complete resection / Surgical approach / Urological malignancies
Cibles, voies et molécules
2008
- Réf : Prog Urol, 2008, 12, 18, S173, suppl. S7

Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser

  Références

 

Human malignancies progress using uncontrolled transduction pathways. Molecules (like VEGF for example) bind to membrane receptors that stimulate transduction pathways (like RAS/MEK/ERK) and activate or inhibit the production of cytoplasmic proteins. Thus it is possible to define targets which can be receptors, molecules or proteins and consequently develop active drugs for targeted therapy.

Mots clés:
Métastase / Carcinome / Voies moléculaires / protéine Cytoplasmique / Traitement ciblé
Mots-clés:
Metastasis / Carcinoma / Pathways / Cytoplasmic protein / Targeted therapy
Comment lire la littérature anglophone d'oncologie médicale ?
2008
- Réf : Prog Urol, 2008, 12, 18, S430, suppl. S7

Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser

  Références

 

Peer review of an english oncological paper needs to focus on the principal evaluation criteria. The total of patients is a crucial element to determine the power of the study. This number must be determinated before starting the trial and must be raised at the end before interpreting results. Results and statistical analysis should be evaluated by the reviewer, keeping in mind that the weight of evidence is not correlated to the “p” value.

Mots clés:
Oncology / Cancérologie / Literature / Valeur p / Statistiques
Mots-clés:
Oncology / Literature / p / value / Statistical
Douleur et métastases osseuses
2008
- Réf : Prog Urol, 2008, 12, 18, S399, suppl. S7

Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser

  Références

 

Average 20% of the cancer patients will have bone metastasis most of time painful and with variable clinical expressions. Due to animal models, the bone metastasis pain is better known and it explains the different treatments mechanisms. After a suitable evaluation of the pain, several therapeutic approaches can be suggested. In addition to the classical analgesics, several medications are known to be efficient in few indications like neuropathic pain. Besides a local surgery, an external radiotherapy or an interventional radiology treatment can often be useful along with a medical treatment. When there is a bone progression, the anti-cancer treatment by chemotherapy, hormonotherapy or targeted therapies must always be reviewed, because if efficient it could have an analgesic action.

Mots clés:
Métastases osseuses / Douleur osseuse / Antalgiques / physiopathologie
Mots-clés:
Bone metastasis / Bone pain / Analgesics / Physiopathology
Évaluation oncogériatrique du sujet âgé ayant un cancer urologique métastatique
2008
- Réf : Prog Urol, 2008, 12, 18, S415, suppl. S7

Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser

  Références

 

The elderly are often the population affected by urologic cancer, especially prostate adenocarcinoma and urothelial tumors. Treatment, especially at the metastatic stage, is the subject of debate due to the problem of iatrogenic consequences compared to potential benefit. A treatment is beneficial when it leads to an increase in the duration and / or quality of life. The evaluation of a patient before treatment should allow estimation of the risk of morbidity, mortality for the patient and treatment should be the tailored to the patient’s physiological condition. The scales of assessment of competitive morbidity and measurement of the level of activity now available provide useful prognostic information to help the urologist to make the best decision concerning the therapeutic approach.

Mots clés:
sujet âgé / cancer de prostate / urologie / Évaluation onco-gériatrique / Qualité de vie
Mots-clés:
Elderly / Prostate cancer / Urology / Evaluation / Onco-geriatry
Événements moléculaires impliqués dans le processus métastatique
2008
- Réf : Prog Urol, 2008, 12, 18, S167, suppl. S7

Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser

  Références

 

The occurrence of metastasis is probably the least characterised process in tumour progression. It is difficult to study, due to the limited access to metastatic tissues, to the multiple steps involved and the long time required to observe metastasis growth, even in model systems. Our understanding of metastatic processes has been changed in recent years by a number of observations and the development of new concepts.

Mots clés:
Métastase / Micrométastase / Cellules souches / Transition épitheliomésenchymateuse / Stroma
Mots-clés:
Metastasis / Micrometastasis / Cancer stem cell / Epithelialmesenchymal transition / Stroma
Gestion des effets secondaires de la suppression androgénique
2008
- Réf : Prog Urol, 2008, 12, 18, S338, suppl. S7

Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser

  Références

 

Androgeno-deprivation is the treatment of reference for metastatic prostate cancer but it generates side effects which are too often ignored by physicians due to concentration on hopes of carcinologic benefit. Hot flashes, metabolic syndrome (body mass and lipid changes), decreased libido, erectile dysfunction, anemia, cognitive dysfunction, gynecomastia, decreased muscular mass and osteoporosis are the most frequent symptoms. They can and must be prevented by advice on physical activity and nutrition.

Mots clés:
cancer de prostate / Androgéno-privation / Métastase
Mots-clés:
Prostate cancer / Androgeno-deprivation / Metastasis
Gestion des toxicités des traitements cibles dans le traitement du cancer du rein métastatique
2008
- Réf : Prog Urol, 2008, 12, 18, S315, suppl. S7

Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser

  Références

 

Important advances have been achieved in the treatment of metastatic renal cell carcinoma in the last few years with the targeted therapy. The consequences on the physiological microvasculature could be at the origin of the adverse effects. It seems important for the clinician to know the physiopathology and the management of these toxicities.

Mots clés:
Anticorps monoclonal / Inhibiteur tyrosine kynase / Inhibiteur mTOR / Toxicité / Métastases
Mots-clés:
Monoclonal Antibody / Tyrosine kynase Inhibitor / mTOR Inhibitor / Toxicity / Metastasis
Indications de la chimiothérapie dans le traitement des cancers urologiques métastatiques
2008
- Réf : Prog Urol, 2008, 12, 18, S219, suppl. S7

Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser

  Références

 

Chemotherapy is useful for many metastatic urological cancer treatments. The main aim is to improve survival and quality of life. Efficacy is directly linked to the type of carcinoma and its chemosensitivity. Very efficient for testis tumors, it is at present the best weapon against metastatic urothelial tumors, especially for transitional cell carcinoma of the bladder. For prostate cancer, chemotherapy is used when metastatic adenocarcinoma has become refractory to hormonal treatment. It is not useful for renal carcinoma. New targeted therapies could soon modify the role of chemotherapy. Thus in clinical trials, some molecules are being tested alone or in association with referent chemotherapies in order to improve results.

Mots clés:
Chimiotherapie / urologie / Métastase / Tumeur urologique / Chimiosensibilité
Mots-clés:
Chemotherapy / Urology / Metastasis / Urological tumor / Chemosensitivity
Indications de la radiothérapie dans le traitement des métastases des cancers urologiques
2008
- Réf : Prog Urol, 2008, 12, 18, S223, suppl. S7

Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser

  Références

 

Radiotherapy is an efficient weapon as part of the treatment of urological carcinoma Metastases. Palliative radiotherapy for bone metastasis has specific caracteristics in Comparison to conventional radiotherapy: rapid initiation, short overall time, efficient and Persistent action and reduced side effects. The indications are often painful symptomatic Lesions. It should be considered as a part of the whole therapeutic schedule for the patient. Generally, this radiotherapy uses a single fraction.

Mots clés:
Métastase / radiothérapie / cancer de prostate / Métastase osseuse
Mots-clés:
Metastasis / radiotherapy / Prostate cancer / Bone metastasis
Intérêt du TEP-FDG dans la prise en charge des métastases des cancers urologiques
2008
- Réf : Prog Urol, 2008, 12, 18, S208, suppl. S7

Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser

  Références

 

FDG-PET is useful for both topographic and metabolic analysis of metastatic cells. It uses a radioactive metabolite integrated into a molecule which penetrates into the tumoral cells. At present, concerning urologic carcinoma, there is no indication for its use in routine to diagnose primary tumors or to explore their development. However it can be useful for minor recurrences for which CT scan and MRI cannot be conclusive. In particular for kidney and urothelial carcinoma it may represent a diagnostic benefit. Nevertheless, interpretation is often made difficult by tracer urinary excretion. New radio tracers are being tested and will probably lead to new indications. Research on androgen receptors and molecular imaging is ongoing.

Mots clés:
voies urinaires / Cancer / prostate / cancer du rein / TEP-FDG
Mots-clés:
urinary tract / Carcinoma / prostate / Renal carcinoma / PET
L'annonce du diagnostic de métastase : les difficultés psychologiques auxquelles le patient est confronté
2008
- Réf : Prog Urol, 2008, 12, 18, S213, suppl. S7

Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser

  Références

 

For the patient learning that there are metastases is frequently comparable to a traumatism. After a period of stupefaction, depression may appear, it must be treated as soon as it is diagnosed. The announcement procedure must favour discussion between patient, pratician and all the health care team. Metastasis announcement management must avoid the patient becoming detached from himself.

Mots clés:
Métastases / Annonce / Consultation d’annonce / traumatisme / Onco-psychologie
Mots-clés:
Metastasis / Annoucement / Traumatic / Onco-psychology
L'histoire naturelle du cancer de prostate métastatique
2008
- Réf : Prog Urol, 2008, 12, 18, S327, suppl. S7

Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser

  Références

 

Prostate cancer is a pathology which progress with successive stages directly dependant on hormonosensitivity. When metastasis occur, cell modifications and biologic transformations lead to disease diffusion. PSA is useful to practically follow the evolution of the prostate cancer but it is probably the molecular biology which probably will be necessary to get pronostic and predictive markers of metastasis power. At each step of the metastatic cascade, it is possible to imagine a specifique targeted therapy for this disease which is today non curable.

Mots clés:
cancer de prostate / Métastase / Hormonodépendance
Mots-clés:
Cancer de prostate / Metastase / Hormonodépendance
La cascade métastatique : angiogenèse et nouveaux concepts
2008
- Réf : Prog Urol, 2008, 12, 18, S156, suppl. S7

Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser

  Références

 

Metastatic progression consists in multiple, progressive, well structured and organized steps, called the metastatic cascade. These steps are becoming clearer, for example, angiogenesis which is absolutely necessary for tumor growth but also for metastatic colonization in the new organ. There are other concepts such as epithelial mesenchymal transition, the premetastatic niche or the metastatic signature theory. They all participate in an irreversible process which escapes from the host control. Tumor progression is highly dependent on genes that mediate the process but also on important extrinsic phenomena such as the tumor microenvironment (basement membranes, the extracellular matrix). The capacity to colonize one organ and not another could be explained by the “seed and soil” theory which postulates that tumor cells (the seed) will only grow in an

Mots clés:
Métastase / angiogenèse / Cascade métastatique / Niche prémétastatique / Transition épitheliomésenchymateuse
Mots-clés:
Metastasis / Angiogenesis / Metastatic cascade / Premetastatic niche / Epithelial mesenchymal transition
Le point sur la scintigraphie osseuse dans les cancers urologiques de l'adulte
2008
- Réf : Prog Urol, 2008, 12, 18, S202, suppl. S7

Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser

  Références

 

Bone scintigraphy still is a first line examination to assess bone extension from urological cancers. Technological progress of note has been the arrival of gamma cameras associated with computed tomography with fusion imaging which increases the scintigraphy performance. Nevertheless, bone scintigraphy indications have decreased particularly for the initial assessment of prostate cancer over many years.

Mots clés:
scintigraphie osseuse / Diphosphonate / cancer de prostate / Métastase osseuse
Mots-clés:
Bone scintigraphy / Diphosphonate / Prostate cancer / Bone metastasis
Le rôle du pathologiste dans le diagnostic des métastases d'origine urologique
2008
- Réf : Prog Urol, 2008, 12, 18, S178, suppl. S7

Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser

  Références

 

Metastases are sometimes the first revelation of urologic cancers. The role of the pathologist in case metastatic disease of unknown origin is to affirm the malignant character of the lesion; provide histological information for possible origins; and to give histological therapeutic arguments. In most of the cases the histological analysis based on cellular morphology is sufficient to suspect a particular origin. In case of poor differentiated carcinoma in addition to the histological analysis, the immunohistochemical study allows the detection of various specific antigens. In this review we approach the various morphological criteria and the interest of the various antibodies to confirm the urologic origin of a metastasis.

Mots clés:
Cancer d’origine inconnue / Métastase de cancers urologiques / Immunohistochimie / Histologie
Mots-clés:
Metastasis / Unknown metastatic tumor / Histology / Immunohischemistry / Urological carcinoma
Les angoisses de mort et la peur de mourir, l'accompagnement de la fin de vie
2008
- Réf : Prog Urol, 2008, 12, 18, S426, suppl. S7

Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser

  Références

 

During metastatic patient follow up, anguish about death is different from the fear of dying. In fact anguish is unconscious and associated with anxiety, on the other hand the fear of dying is a reaction to the threat of imminent death. Physical pain and isolation are factors that increase the pangs of death. The support of friends and family constitutes a real benefit for the treatment of patients during this period.

Mots clés:
Carcinome / Cancer / Métastase / Mort / Anxiété
Mots-clés:
Carcinoma / Metastasis / Death / Anxiety
Les métastases des cancers urologiques : historique, définitions et enjeux
2008
- Réf : Prog Urol, 2008, 12, 18, S143, suppl. S7

Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser

  Références

 

The word metastasis came from grec “I move”. Bayle and Récamier were the first to show the relation between a secondary tumor from a primitive carcinoma but it is really Stephen Paget who is the father of the “seed and soil” theory to explain metastasis dissemination. Since, a lot of works have been done to better understand the metastasis physiopathology and in particular Judah Folkman participated very actively in angiogenesis mechanisms research. Today, even if all is not totally understood, physicians know that metastasis is a decisive event in the carcinoma story.

Mots clés:
Métastase / Stephen Paget / Bayle / Récamier / Folkman
Mots-clés:
Metastasis / Stephen Paget / Bayle / Récamier / Folkman
Les métastases des cancers urologiques Rapport 2008 du 102 e congrès de l'AFU
2008
- Réf : Prog Urol, 2008, 12, 18, S141, suppl. S7

Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser

 

 

 

 

 

Mots clés:
Thierry / Arnaud
Mots-clés:
Kidney / stone / renal failure / Staghorn / dialysis
Les métastases des cancers urothéliaux : place de la chimiothérapie
2008
- Réf : Prog Urol, 2008, 12, 18, S261, suppl. S7

Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser

  Références

 

Chemotherapy is the first line treatment for metastatic urothelial carcinoma. Cytotoxic drugs, in particular cisplatin-based, play an important role in the first line treatment of metastatic patients. Since the 80’s, no drug association has done better than M-VAC (methotrexate, vinblastin, adriamycin et cisplatin) in terms of response rate and 5-year survival rate. The Gemcitabin-Cisplatin (GC) association gives less side effects with similar results. The use of G-CSF (granulocyte/colony stimulating factor) with M-VAC has led to propose a new schedule with dose intensification and better tolerance: M-VAC-HD. In 2008, GC and M-VAC-HD are the two recommended drug associations. Unfortunately, some patients cannot be treated with these toxic drugs, in particular because of Cisplatin toxicity for kidney function. Therefore it is important to continue research to improve tolerance and anti-tumoral efficacy. After failure of first line therapy no consensual drugs exist in the second line, ongoing trials and new agents should increase options in the future.

Mots clés:
Carcinoma Urothélial / Cancer de vessie / M-VAC / Cisplatine / Gemcitabine
Mots-clés:
Urothelial carcinoma / Bladder carcinoma / M-VAC / Cisplatine / Gemcitabine
Les sites métastatiques atypiques des cancers de la prostate
2008
- Réf : Prog Urol, 2008, 12, 18, S357, suppl. S7

Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser

  Références

 

The bone tissue is the most frequent site for prostate carcinoma metastasis. Nevertheless many other areas have also been described. Using Pubmed and Cochrane the most exhaustive research possible has been carried out to list these secondary prostate carcinoma lesions.

Mots clés:
cancer de prostate / Métastase / Épidémiologie
Mots-clés:
Prostate carcinoma / Metastasis / epidemiology
Les soins de support pour les patients souffrant d'un cancer urologique métastasé
2008
- Réf : Prog Urol, 2008, 12, 18, S410, suppl. S7

Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser

  Références

 

Supportive cancer care is defined as “all the care and support necessary for the patient throughout the illness together with specific oncological treatment”. This includes side effect treatments, advice to facilitate access to all therapeutic approaches (i. e. home care) and to keep the patient in the social community. Acute pain centers and palliative care units are at the core of this new approach. In urology, the example of patients with bone metastasis demonstrates the usefulness of this concept. In fact it participates in: antalgic treatment, prevention of bone events (bisphosphonates), adaptation of daily life with a handicap, access to physiotherapy, psychological help. It also includes financial allowances. In France, supportive care centers are being set up in most hospital to facilitate the coordination of all the multidisciplinary teams.

Mots clés:
Soin de support en oncologie / Hospitalisation à domicile / Soin de support / Soin palliatif
Mots-clés:
Supportive cancer care / Home care / Supportive care / Palliative care
Métastases des cancers du pénis
2008
- Réf : Prog Urol, 2008, 12, 18, S392, suppl. S7

Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser

  Références

 

Penile cancer is a rare carcinoma and visceral metastases are uncommon. Metastasis diagnosis is carried out with TDM and MRI but markers can sometimes be helpful (ie SSCAg). There is no referent chemotherapy, a trial has been started (CAVER).

Mots clés:
cancer du pénis / Métastase / Chimiotherapie
Mots-clés:
Penile cancer / Metastasis / Chemotherapy
Physiopathologie de la métastase : du primitif au secondaire
2008
- Réf : Prog Urol, 2008, 12, 18, S147, suppl. S7

Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser

  Références

 

Metastasis genesis is the result of a series of many steps which make a tumoral cell localised in a primary tumor move and graft onto another organ to form a new tumor. Tumoral cells must go through the following steps: primary tumor formation, proliferation and angiogenesis, deep tissue invasion and arrival in the circulatory system, preparation for travel, migration, embolization in an organ, attachment to the wall of blood vessel, exit from the vessel, adaptation to the micro-surrounding, anchorage and neo-angiogenesis which corresponds to the metastasis establishment. At each step, there are defence and regulation mechanisms which, when they fail, lead to metastatic dissemination.

Mots clés:
Métastase / génétique / angiogenèse / physiopathologie / Proliferation
Mots-clés:
Metastasis / Genesis / Angiogenesis / Physiopathology / Proliferation
Physiopathologie, diagnostic et prise en charge des métastases osseuses du cancer de prostate
2008
- Réf : Prog Urol, 2008, 12, 18, S349, suppl. S7

Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser

  Références

 

Bone metastasis is very frequent in prostate cancer. Diagnosis is generally easy to make with scintigraphy and it can be confirmed by TDM and RMI. Before metastasis become symptomatic, treatment includes physical and nutritional advice with drugs to prevent bone events (pain, fracture, compression and hypercalcemia). Associated with a effective hormonal treatment, radiotherapy, surgery and analgesics are the principal treatments for symptomatic bone metastasis. Bisphosphonates play a very important role to prevent bone mass loss and to reduce bone complication events. Endothelin inhibitors belong to a new exciting concept to treat these bone metastases, data are needed in order to use them routinely.

Mots clés:
Métastase osseuse / cancer de prostate / Ostéoblaste / Ostéoclaste / Bisphophonates
Mots-clés:
Bone metastasis / Prostate cancer / Ostéoblast / Ostéoclast / Bisphosphonate
Place de l'hormonothérapie dans le traitement du cancer de prostate métastatique
2008
- Réf : Prog Urol, 2008, 12, 18, S332, suppl. S7

Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser

  Références

 

Androgen privation is considered as the referent first line treatment for metastatic prostate cancer. Based on LHRH agonist, different therapeutic schedule included maximum androgenic blokage, intermittent treatment and associations with other drugs like oestrogen leading to possible hormonal manipulations. Since metastasis is confirmed, immediate treatment with continue LHRH agonist is the French Association of Urology (AFU) AFU recommendations treatment for metastatic prostate cancer but intermittent treatment can be considered as an option.

Mots clés:
cancer de prostate / Métastase / Hormonothérapie / Luteinising hormonereleasing hormone agonist / Anti-androgènes
Mots-clés:
Prostate cancer / Metastasis / Hormonotherapy / Luteinising hormonereleasing hormone agonist / Anti-androgen
Place et modalités de la chirurgie des métastases hépatiques des cancers urologiques
2008
- Réf : Prog Urol, 2008, 12, 18, S256, suppl. S7

Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser

  Références

 

The liver is the third localisation of metastatic urological tumours after the bone and the lungs. Most frequently, it occurs as a multimetastatic disease for which surgery is not feasible. Nevertheless, when the metastasis is unique and when resection can be complete, it can be proposed if the localisation and the global prognosis permit. Recent therapeutic progress, including new improved drugs, progress in surgical procedures and the multisciplinary approach, lead to propose tumorectomy or hepatectomy for a few selected patients with hepatic metastasis from urological tumours.

Mots clés:
urologie / Cancer / Métastase / Hépatectomie / Foie
Mots-clés:
Urology / Carcinoma / Metastasis / Hepatectomy / Liver
Place et Modalités de la chirurgie des métastases vertébrales des cancers urologiques
2008
- Réf : Prog Urol, 2008, 12, 18, S239, suppl. S7

Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser

  Références

 

The improved survival rate in urologic carcinoma notably due to anti-angiogenic drugs is directly associated with increased incidence of spinal metastases. During spinal metastasis cord compression it has been proved that surgery associated with radiotherapy gives better results that radiotherapy alone. The neurotoxic risk of the spine metastasis must be evaluated before neurological signs appear in order to propose, if necessary decompressive surgery with stabilisation of the lesion. The choices of therapeutic approach are quite large ranging from percutaneous cimentoplasty to vertebral replacement. It is essential that the initial treatment of metastasis be discussed before neurologic signs appear.

Mots clés:
Métastase cérébrale / Chirurgie / radiothérapie / urologie / cancer du rein
Mots-clés:
Spine metastasis / surgery / radiotherapy / Urology / Renal carcinoma
Prise en charge chirurgicale des métastases rétropéritonéales des tumeurs germinales du testicule
2008
- Réf : Prog Urol, 2008, 12, 18, S382, suppl. S7


Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser


The surgery of residual retroperitoneal tumors is a compulsory prolongation of chemotherapy in non seminomatous germ cell tumors. The requirements of total resection must be respected. High morbidity of bilateral lymphadenectomy for large bulky disease is possible and implies specialised surgery. The extent of surgery can be limited to a template area in specific circumstances.

Mots clés:
Curage Lomboaortique / Masse résiduelle / Chirurgie de rattrapage / Cancer du testicule / Métastase
Mots-clés:
Lymphadenectomy / Residual mass / Salvage surgery / Testis carcinoma / metastasis
Prise en charge des métastases cérébrales des cancers urologiques
2008
- Réf : Prog Urol, 2008, 12, 18, S234, suppl. S7

Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser

  Références

 

Brain metastases account for 30 to 40% of all brain tumors in adults. Even if urological carcinomas are not very common, anti-angiogenic drugs have transformed their prognosis, leading physicians to consider their specific treatment.

For the majority of cases, surgery is quite simple with low associated morbidity. Depending on the size and the location, surgery or stereotaxic radiotherapy should be discussed. As soon as the metastasis is suspected a neurosurgerical opinion must be sought before beginning any treatment to coordinate the global management.

Mots clés:
Métastase cérébrale / Chirurgie / radiothérapie / urologie / cancer du rein
Mots-clés:
Brain metastasis / surgery / radiotherapy / Urology / Renal carcinoma